Localized Panniculitis and Subsequent Lipoatrophy with Subcutaneous Glatiramer Acetate (Copaxone ® ) Injection for the Treatment of Multiple Sclerosis

Author： Noemi Soós   Kaweh Shakery   Ulrich Mrowietz  

Publisher： Adis International

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.5, Iss.5, 2004-01, pp. : 357-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

By Simpson D.   Noble S.   Perry C.  

BioDrugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Application of Glatiramer Acetate to Neurodegenerative Diseases beyond Multiple Sclerosis: The Need for Disease-Specific Approaches

By Schwartz Michal   Bukshpan Shay   Kunis Gilad  

BioDrugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 293-299

Adis International

Access to resources Recommend Favorite

Spotlight on Subcutaneous Recombinant Interferon- -1a (Rebif ® ) in Relapsing-Remitting Multiple Sclerosis

By Murdoch David   Lyseng-Williamson Katherine A.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 323-325

Adis International

Access to resources Recommend Favorite

Phosphodiesterase Type 4 Inhibitors: Potential in the Treatment of Multiple Sclerosis?

By Dinter H.  

BioDrugs, Vol. 13, Iss. 2, 2000-02 ,pp. : 87-94

Adis International

Access to resources Recommend Favorite

Treatment of Secondary Progressive Multiple Sclerosis: Current Recommendations and Future Prospects

By Rice G.P.A.  

BioDrugs, Vol. 12, Iss. 4, 1999-10 ,pp. : 267-277

Adis International

Access to resources Recommend Favorite